This report aims to provide a comprehensive presentation of the global market for Oral Cancer Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Cancer Therapeutic. This report contains market size and forecasts of Oral Cancer Therapeutic in global, including the following market information:
Global Oral Cancer Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oral Cancer Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Targeted Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Cancer Therapeutic include AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., Endo International Plc, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Mylan NV, Pfizer Inc. and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Cancer Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Cancer Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oral Cancer Therapeutic Market Segment Percentages, by Type, 2022 (%)
Targeted Therapy
Chemotherapy
Global Oral Cancer Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oral Cancer Therapeutic Market Segment Percentages, by Application, 2022 (%)
Floor of Mouth Cancer
Gum Cancer
Hard Palate Cancer
Inner Cheek Cancer (Buccal Mucosa Cancer)
Lip Cancer
Others
Global Oral Cancer Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oral Cancer Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Cancer Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oral Cancer Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Bristol-Myers Squibb Co.
Eli Lilly and Co.
Endo International Plc
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Mylan NV
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Cancer Therapeutic, market overview.
Chapter 2: Global Oral Cancer Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Oral Cancer Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Cancer Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Cancer Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Cancer Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Cancer Therapeutic Overall Market Size
2.1 Global Oral Cancer Therapeutic Market Size: 2022 VS 2029
2.2 Global Oral Cancer Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oral Cancer Therapeutic Players in Global Market
3.2 Top Global Oral Cancer Therapeutic Companies Ranked by Revenue
3.3 Global Oral Cancer Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Oral Cancer Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oral Cancer Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Cancer Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Oral Cancer Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Oral Cancer Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Cancer Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.2 By Type - Global Oral Cancer Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Oral Cancer Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Oral Cancer Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Cancer Therapeutic Market Size, 2022 & 2029
5.1.2 Floor of Mouth Cancer
5.1.3 Gum Cancer
5.1.4 Hard Palate Cancer
5.1.5 Inner Cheek Cancer (Buccal Mucosa Cancer)
5.1.6 Lip Cancer
5.1.7 Others
5.2 By Application - Global Oral Cancer Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Oral Cancer Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Oral Cancer Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oral Cancer Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global Oral Cancer Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Oral Cancer Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Oral Cancer Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oral Cancer Therapeutic Revenue, 2018-2029
6.3.2 US Oral Cancer Therapeutic Market Size, 2018-2029
6.3.3 Canada Oral Cancer Therapeutic Market Size, 2018-2029
6.3.4 Mexico Oral Cancer Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oral Cancer Therapeutic Revenue, 2018-2029
6.4.2 Germany Oral Cancer Therapeutic Market Size, 2018-2029
6.4.3 France Oral Cancer Therapeutic Market Size, 2018-2029
6.4.4 U.K. Oral Cancer Therapeutic Market Size, 2018-2029
6.4.5 Italy Oral Cancer Therapeutic Market Size, 2018-2029
6.4.6 Russia Oral Cancer Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Oral Cancer Therapeutic Market Size, 2018-2029
6.4.8 Benelux Oral Cancer Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oral Cancer Therapeutic Revenue, 2018-2029
6.5.2 China Oral Cancer Therapeutic Market Size, 2018-2029
6.5.3 Japan Oral Cancer Therapeutic Market Size, 2018-2029
6.5.4 South Korea Oral Cancer Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Oral Cancer Therapeutic Market Size, 2018-2029
6.5.6 India Oral Cancer Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oral Cancer Therapeutic Revenue, 2018-2029
6.6.2 Brazil Oral Cancer Therapeutic Market Size, 2018-2029
6.6.3 Argentina Oral Cancer Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oral Cancer Therapeutic Revenue, 2018-2029
6.7.2 Turkey Oral Cancer Therapeutic Market Size, 2018-2029
6.7.3 Israel Oral Cancer Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Oral Cancer Therapeutic Market Size, 2018-2029
6.7.5 UAE Oral Cancer Therapeutic Market Size, 2018-2029
7 Oral Cancer Therapeutic Companies Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Company Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Oral Cancer Therapeutic Major Product Offerings
7.1.4 AstraZeneca Plc Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Plc Key News & Latest Developments
7.2 Bristol-Myers Squibb Co.
7.2.1 Bristol-Myers Squibb Co. Company Summary
7.2.2 Bristol-Myers Squibb Co. Business Overview
7.2.3 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Major Product Offerings
7.2.4 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Co. Key News & Latest Developments
7.3 Eli Lilly and Co.
7.3.1 Eli Lilly and Co. Company Summary
7.3.2 Eli Lilly and Co. Business Overview
7.3.3 Eli Lilly and Co. Oral Cancer Therapeutic Major Product Offerings
7.3.4 Eli Lilly and Co. Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Co. Key News & Latest Developments
7.4 Endo International Plc
7.4.1 Endo International Plc Company Summary
7.4.2 Endo International Plc Business Overview
7.4.3 Endo International Plc Oral Cancer Therapeutic Major Product Offerings
7.4.4 Endo International Plc Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Endo International Plc Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Company Summary
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Oral Cancer Therapeutic Major Product Offerings
7.6.4 Merck & Co., Inc. Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Merck & Co., Inc. Key News & Latest Developments
7.7 Mylan NV
7.7.1 Mylan NV Company Summary
7.7.2 Mylan NV Business Overview
7.7.3 Mylan NV Oral Cancer Therapeutic Major Product Offerings
7.7.4 Mylan NV Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.7.5 Mylan NV Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Oral Cancer Therapeutic Major Product Offerings
7.8.4 Pfizer Inc. Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Oral Cancer Therapeutic Major Product Offerings
7.9.4 Sanofi Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oral Cancer Therapeutic Market Opportunities & Trends in Global Market
Table 2. Oral Cancer Therapeutic Market Drivers in Global Market
Table 3. Oral Cancer Therapeutic Market Restraints in Global Market
Table 4. Key Players of Oral Cancer Therapeutic in Global Market
Table 5. Top Oral Cancer Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oral Cancer Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oral Cancer Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oral Cancer Therapeutic Product Type
Table 9. List of Global Tier 1 Oral Cancer Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Cancer Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oral Cancer Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oral Cancer Therapeutic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oral Cancer Therapeutic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oral Cancer Therapeutic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oral Cancer Therapeutic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oral Cancer Therapeutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oral Cancer Therapeutic Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca Plc Company Summary
Table 31. AstraZeneca Plc Oral Cancer Therapeutic Product Offerings
Table 32. AstraZeneca Plc Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Plc Key News & Latest Developments
Table 34. Bristol-Myers Squibb Co. Company Summary
Table 35. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Product Offerings
Table 36. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Co. Key News & Latest Developments
Table 38. Eli Lilly and Co. Company Summary
Table 39. Eli Lilly and Co. Oral Cancer Therapeutic Product Offerings
Table 40. Eli Lilly and Co. Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly and Co. Key News & Latest Developments
Table 42. Endo International Plc Company Summary
Table 43. Endo International Plc Oral Cancer Therapeutic Product Offerings
Table 44. Endo International Plc Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 45. Endo International Plc Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd. Company Summary
Table 47. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Product Offerings
Table 48. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 50. Merck & Co., Inc. Company Summary
Table 51. Merck & Co., Inc. Oral Cancer Therapeutic Product Offerings
Table 52. Merck & Co., Inc. Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co., Inc. Key News & Latest Developments
Table 54. Mylan NV Company Summary
Table 55. Mylan NV Oral Cancer Therapeutic Product Offerings
Table 56. Mylan NV Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 57. Mylan NV Key News & Latest Developments
Table 58. Pfizer Inc. Company Summary
Table 59. Pfizer Inc. Oral Cancer Therapeutic Product Offerings
Table 60. Pfizer Inc. Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Inc. Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Oral Cancer Therapeutic Product Offerings
Table 64. Sanofi Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Ltd. Company Summary
Table 67. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue (US$, Mn) & (2018-2023)
Table 69. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
List of Figures
Figure 1. Oral Cancer Therapeutic Segment by Type in 2022
Figure 2. Oral Cancer Therapeutic Segment by Application in 2022
Figure 3. Global Oral Cancer Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Cancer Therapeutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oral Cancer Therapeutic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Cancer Therapeutic Revenue in 2022
Figure 8. By Type - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 16. US Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 20. Germany Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 21. France Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 28. China Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 32. India Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 34. Brazil Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oral Cancer Therapeutic Revenue Market Share, 2018-2029
Figure 37. Turkey Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oral Cancer Therapeutic Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca Plc Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly and Co. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Endo International Plc Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co., Inc. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mylan NV Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Inc. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
